Ken Griffin Treace Medical Concepts, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$5.01 - $8.45 $27,054 - $45,629	5,400 Added 4.29%	131,400 $762,000
Q2 2024 Aug 14, 2024	BUY	$4.17 - $12.62 $466,623 - $1.41 Million	111,900 Added 793.62%	126,000 $837,000
Q1 2024 May 15, 2024	SELL	$11.48 - $15.86 $135,464 - $187,148	-11,800 Reduced 45.56%	14,100 $184,000
Q4 2023 Feb 14, 2024	BUY	$6.03 - $12.88 $60,300 - $128,800	10,000 Added 62.89%	25,900 $330,000
Q3 2023 Nov 14, 2023	BUY	$12.16 - $24.87 $193,344 - $395,433	15,900 New	15,900 $208,000
Q1 2023 May 15, 2023	BUY	$20.23 - $26.22 $220,507 - $285,798	10,900 Added 84.5%	23,800 $599,000
Q4 2022 Feb 14, 2023	BUY	$20.54 - $24.67 $264,966 - $318,243	12,900 New	12,900 $296,000

137

39.7M

352K

269K

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $423M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.